{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:14:25Z","timestamp":1786986865731,"version":"build-2736575974"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100006098","name":"Radiological Society of North America","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006098","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalimaging.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Imaging"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.clinimag.2020.11.050","type":"journal-article","created":{"date-parts":[[2020,12,3]],"date-time":"2020-12-03T19:31:13Z","timestamp":1607023873000},"page":"101-107","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Symptomatic ductal carcinoma in situ (DCIS): Upstaging risk and predictors"],"prefix":"10.1016","volume":"73","author":[{"given":"Sheila L.","family":"Venkatesh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tawakalitu O.","family":"Oseni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manisha","family":"Bahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.clinimag.2020.11.050_bb0005","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/s41416-019-0478-6","article-title":"Ductal carcinoma in situ: to treat or not to treat, that is the question","volume":"121","author":"van Seijen","year":"2019","journal-title":"Br J Cancer"},{"issue":"3","key":"10.1016\/j.clinimag.2020.11.050_bb0010","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s10549-006-9167-2","article-title":"Is there a role of sentinel lymph node biopsy in ductal carcinoma in situ?: analysis of 587 cases","volume":"98","author":"Goyal","year":"2006","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"10.1016\/j.clinimag.2020.11.050_bb0015","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/cncr.22435","article-title":"Underestimation of malignancy of breast core-needle biopsy: concepts and precise overall and category-specific estimates","volume":"109","author":"Houssami","year":"2007","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.clinimag.2020.11.050_bb0020","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1148\/radiol.11102368","article-title":"Ductal carcinoma in situ at core-needle biopsy: meta-analysis of underestimation and predictors of invasive breast cancer","volume":"260","author":"Brennan","year":"2011","journal-title":"Radiology"},{"issue":"5","key":"10.1016\/j.clinimag.2020.11.050_bb0025","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1245\/s10434-010-1438-9","article-title":"Accuracy of a preoperative model for predicting invasive breast cancer in women with ductal carcinoma-in-situ on vacuum-assisted core needle biopsy","volume":"18","author":"Houssami","year":"2011","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.clinimag.2020.11.050_bb0030","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.breast.2012.06.012","article-title":"Factors associated with upstaging from ductal carcinoma in situ following core needle biopsy to invasive cancer in subsequent surgical excision","volume":"21","author":"Kim","year":"2012","journal-title":"Breast"},{"issue":"5","key":"10.1016\/j.clinimag.2020.11.050_bb0035","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/j.breast.2012.06.009","article-title":"Predictors of invasive breast cancer and lymph node involvement in ductal carcinoma in situ initially diagnosed by vacuum-assisted breast biopsy: experience of 733 cases","volume":"21","author":"Trentin","year":"2012","journal-title":"Breast"},{"issue":"4","key":"10.1016\/j.clinimag.2020.11.050_bb0040","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.breast.2012.11.002","article-title":"Prediction of underestimated invasiveness in patients with ductal carcinoma in situ of the breast on percutaneous biopsy as rationale for recommending concurrent sentinel lymph node biopsy","volume":"22","author":"Schulz","year":"2013","journal-title":"Breast"},{"issue":"2","key":"10.1016\/j.clinimag.2020.11.050_bb0045","doi-asserted-by":"crossref","first-page":"246","DOI":"10.2214\/AJR.17.18778","article-title":"Ductal carcinoma in situ: the whole truth","volume":"210","author":"Parikh","year":"2018","journal-title":"AJR Am J Roentgenol"},{"issue":"5","key":"10.1016\/j.clinimag.2020.11.050_bb0050","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1148\/rg.305095073","article-title":"Radiologic-pathologic correlation of ductal carcinoma in situ","volume":"30","author":"Yamada","year":"2010","journal-title":"Radiographics"},{"issue":"3","key":"10.1016\/j.clinimag.2020.11.050_bb0055","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1093\/jbi\/wbz039","article-title":"Ductal carcinoma in situ: current concepts in biology, imaging, and treatment","volume":"1","author":"Shehata","year":"2019","journal-title":"J Breast Imaging"},{"issue":"3","key":"10.1016\/j.clinimag.2020.11.050_bb0060","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ejso.2013.12.013","article-title":"The frequency of presentation and clinico-pathological characteristics of symptomatic versus screen detected ductal carcinoma in situ of the breast","volume":"40","author":"Barnes","year":"2014","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"10.1016\/j.clinimag.2020.11.050_bb0065","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s10549-019-05362-1","article-title":"Reliability of preoperative breast biopsies showing ductal carcinoma in situ and implications for non-operative treatment: a cohort study","volume":"178","author":"Mannu","year":"2019","journal-title":"Breast Cancer Res Treat"},{"issue":"10","key":"10.1016\/j.clinimag.2020.11.050_bb0070","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.6004\/jnccn.2009.0070","article-title":"NCCN clinical practice guidelines in oncology: breast cancer screening and diagnosis","volume":"7","author":"Bevers","year":"2009","journal-title":"J Natl Compr Canc Netw"},{"issue":"12","key":"10.1016\/j.clinimag.2020.11.050_bb0075","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/j.ejca.2015.05.008","article-title":"Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ - the LORD study","volume":"51","author":"Elshof","year":"2015","journal-title":"Eur J Cancer"},{"issue":"16","key":"10.1016\/j.clinimag.2020.11.050_bb0080","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1016\/j.ejca.2015.07.017","article-title":"Addressing overtreatment of screen detected DCIS; the LORIS trial","volume":"51","author":"Francis","year":"2015","journal-title":"Eur J Cancer"},{"issue":"11","key":"10.1016\/j.clinimag.2020.11.050_bb0085","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/ans.13659","article-title":"Not all ductal carcinoma in situ is created equal: can we avoid surgery for low-risk ductal carcinoma in situ?","volume":"86","author":"Lippey","year":"2016","journal-title":"ANZ J Surg"},{"issue":"3","key":"10.1016\/j.clinimag.2020.11.050_bb0090","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-026797","article-title":"The COMET (Comparison of Operative versus Monitoring and Endocrine Therapy) trial: a phase III randomised controlled clinical trial for low-risk ductal carcinoma in situ (DCIS)","volume":"9","author":"Hwang","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/j.clinimag.2020.11.050_bb0095","author":"NIPH Clinical Trials Search"},{"key":"10.1016\/j.clinimag.2020.11.050_bb0100","author":"American College of Radiology"},{"key":"10.1016\/j.clinimag.2020.11.050_bb0105","series-title":"ACR BI-RADS Atlas, Breast Imaging Reporting and Data System","article-title":"ACR BI-RADS mammography","author":"Sickles","year":"2013"},{"issue":"6","key":"10.1016\/j.clinimag.2020.11.050_bb0110","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1524-4741.2007.00513.x","article-title":"BI-RADS MRI enhancement characteristics of ductal carcinoma in situ","volume":"13","author":"Rosen","year":"2007","journal-title":"Breast J"},{"issue":"3","key":"10.1016\/j.clinimag.2020.11.050_bb0115","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1148\/radiol.2017161449","article-title":"Impact of preoperative breast MR imaging and MR-guided surgery on diagnosis and surgical outcome of women with invasive breast cancer with and without DCIS component","volume":"284","author":"Kuhl","year":"2017","journal-title":"Radiology"},{"issue":"3","key":"10.1016\/j.clinimag.2020.11.050_bb0120","doi-asserted-by":"crossref","first-page":"310","DOI":"10.6004\/jnccn.2018.0012","article-title":"Breast cancer, version 4.2017, NCCN clinical practice guidelines in oncology","volume":"16","author":"Gradishar","year":"2018","journal-title":"J Natl Compr Canc Netw"}],"container-title":["Clinical Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0899707120305015?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0899707120305015?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T11:44:13Z","timestamp":1760269453000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0899707120305015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":24,"alternative-id":["S0899707120305015"],"URL":"https:\/\/doi.org\/10.1016\/j.clinimag.2020.11.050","relation":{},"ISSN":["0899-7071"],"issn-type":[{"value":"0899-7071","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Symptomatic ductal carcinoma in situ (DCIS): Upstaging risk and predictors","name":"articletitle","label":"Article Title"},{"value":"Clinical Imaging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinimag.2020.11.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}